291 related articles for article (PubMed ID: 16518519)
1. Venoruton vs Daflon: evaluation of effects on quality of life in chronic venous insufficiency.
Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Di Renzo A; Ruffini I; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cornelli U; Hosoi M; Cacchio M
Angiology; 2006; 57(2):131-8. PubMed ID: 16518519
[TBL] [Abstract][Full Text] [Related]
2. HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study.
Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Di Renzo A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M
Angiology; 2005; 56(1):1-8. PubMed ID: 15678250
[TBL] [Abstract][Full Text] [Related]
3. Oxerutins (Venoruton): efficacy in chronic venous insufficiency--a double-blind, randomized, controlled study.
Petruzzellis V; Troccoli T; Candiani C; Guarisco R; Lospalluti M; Belcaro G; Dugall M
Angiology; 2002; 53(3):257-63. PubMed ID: 12025912
[TBL] [Abstract][Full Text] [Related]
4. HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: an independent prospective, controlled, randomized trial.
Belcaro G; Cesarone MR; Bavera P; Ricci A; Renton S; Leon M; Ippolito E; Dugall M; Acerbi G
J Cardiovasc Pharmacol Ther; 2002 Jul; 7(3):139-45. PubMed ID: 12232562
[TBL] [Abstract][Full Text] [Related]
5. Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assEssment and quaLity of lIfe improvEment with micronized Flavonoids.
Jantet G
Angiology; 2002; 53(3):245-56. PubMed ID: 12025911
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings.
Unkauf M; Rehn D; Klinger J; de la Motte S; Grossmann K
Arzneimittelforschung; 1996 May; 46(5):478-82. PubMed ID: 8737630
[TBL] [Abstract][Full Text] [Related]
7. Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study.
Ippolito E; Belcaro G; Dugall M; Cesarone MR; Feragalli B; Errichi BM; Gizzi G; Pellegrini L; Ledda A; Luzzi R; Ricci A; Bavera P; Hosoi M; Corsi M; Errichi S
Panminerva Med; 2011 Sep; 53(3 Suppl 1):13-9. PubMed ID: 22108472
[TBL] [Abstract][Full Text] [Related]
8. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
[TBL] [Abstract][Full Text] [Related]
9. HR, 0-(beta-hydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study.
Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Stuard S; Corsi M
Angiology; 2005; 56(2):165-72. PubMed ID: 15793606
[TBL] [Abstract][Full Text] [Related]
10. Comparison between the efficacy and tolerability of oxerutins and troxerutin in the treatment of patients with chronic venous insufficiency.
Rehn D; Golden G; Nocker W; Diebschlag W; Lehmacher W
Arzneimittelforschung; 1993 Oct; 43(10):1060-3. PubMed ID: 8267669
[TBL] [Abstract][Full Text] [Related]
11. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study.
Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162
[TBL] [Abstract][Full Text] [Related]
12. RELIEF study: first consolidated European data. Reflux assEssment and quaLity of lIfe improvement with micronized Flavonoids.
Jantet G
Angiology; 2000 Jan; 51(1):31-7. PubMed ID: 10667641
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study.
Cesarone MR; Belcaro G; Rohdewald P; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Hosoi M; Stuard S; Corsi M
Clin Appl Thromb Hemost; 2006 Apr; 12(2):205-12. PubMed ID: 16708123
[TBL] [Abstract][Full Text] [Related]
14. Three treatments for chronic venous insufficiency: escin, hydroxyethylrutoside, and Daflon.
Frick RW
Angiology; 2000 Mar; 51(3):197-205. PubMed ID: 10744007
[TBL] [Abstract][Full Text] [Related]
15. Variations in plasma free radicals in patients with venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized trial.
Cesarone MR; Incandela L; DeSanctis MT; Belcaro G; Dugall M; Acerbi G
J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S25-8. PubMed ID: 12011970
[TBL] [Abstract][Full Text] [Related]
16. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
Amato C
Angiology; 1994 Jun; 45(6 Pt 2):531-6. PubMed ID: 8203783
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials.
Kakkos SK; Nicolaides AN
Int Angiol; 2018 Apr; 37(2):143-154. PubMed ID: 29385792
[TBL] [Abstract][Full Text] [Related]
18. Laser Doppler and transcutaneous oximetry: modern investigations to assess drug efficacy in chronic venous insufficiency.
Belcaro G; Cesarone MR; de Sanctis MT; Incandela L; Laurora G; Février B; Wargon C; De Gregoris P
Int J Microcirc Clin Exp; 1995; 15 Suppl 1():45-9. PubMed ID: 8748889
[TBL] [Abstract][Full Text] [Related]
19. From symptoms to leg edema: efficacy of Daflon 500 mg.
Nicolaides AN
Angiology; 2003; 54 Suppl 1():S33-44. PubMed ID: 12934755
[TBL] [Abstract][Full Text] [Related]
20. Veno-active drugs for chronic venous disease: A randomized, double-blind, placebo-controlled parallel-design trial.
Belczak SQ; Sincos IR; Campos W; Beserra J; Nering G; Aun R
Phlebology; 2014 Aug; 29(7):454-60. PubMed ID: 23761871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]